310 related articles for article (PubMed ID: 19857606)
1. Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery.
Gupta H; Aqil M; Khar RK; Ali A; Bhatnagar A; Mittal G
Nanomedicine; 2010 Apr; 6(2):324-33. PubMed ID: 19857606
[TBL] [Abstract][Full Text] [Related]
2. Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery.
Gupta H; Aqil M; Khar RK; Ali A; Bhatnagar A; Mittal G
J Drug Target; 2011 Jul; 19(6):409-17. PubMed ID: 20678034
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticles laden in situ gel for sustained ocular drug delivery.
Gupta H; Aqil M; Khar RK; Ali A; Bhatnagar A; Mittal G
J Pharm Bioallied Sci; 2013 Apr; 5(2):162-5. PubMed ID: 23833523
[TBL] [Abstract][Full Text] [Related]
4. Formulation and comparative evaluation of HPMC and water soluble chitosan-based sparfloxacin nanosuspension for ophthalmic delivery.
Ambhore NP; Dandagi PM; Gadad AP
Drug Deliv Transl Res; 2016 Feb; 6(1):48-56. PubMed ID: 26545605
[TBL] [Abstract][Full Text] [Related]
5. A Novel Method for Preparing Surface-Modified Fluocinolone Acetonide Loaded PLGA Nanoparticles for Ocular Use: In Vitro and In Vivo Evaluations.
Salama AH; Mahmoud AA; Kamel R
AAPS PharmSciTech; 2016 Oct; 17(5):1159-72. PubMed ID: 26589410
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticles laden in situ gel of levofloxacin for enhanced ocular retention.
Gupta H; Aqil M; Khar RK; Ali A; Bhatnagar A; Mittal G
Drug Deliv; 2013; 20(7):306-9. PubMed ID: 24044648
[TBL] [Abstract][Full Text] [Related]
7. Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and
Öztürk AA; Yenilmez E; Şenel B; Kıyan HT; Güven UM
Drug Dev Ind Pharm; 2020 Apr; 46(4):682-695. PubMed ID: 32281428
[No Abstract] [Full Text] [Related]
8. Preparation and In Vitro/Ex Vivo Evaluation of Moxifloxacin-Loaded PLGA Nanosuspensions for Ophthalmic Application.
Mudgil M; Pawar PK
Sci Pharm; 2013; 81(2):591-606. PubMed ID: 23833723
[TBL] [Abstract][Full Text] [Related]
9. Poly(D,L-lactide-co-glycolide) nanoparticles encapsulated fluorescent isothiocyanate and paclitaxol: preparation, release kinetics and anticancer effect.
Yang H; Li K; Liu Y; Liu Z; Miyoshi H
J Nanosci Nanotechnol; 2009 Jan; 9(1):282-7. PubMed ID: 19441308
[TBL] [Abstract][Full Text] [Related]
10. In vivo tissue distribution and efficacy studies for cyclosporin A loaded nano-decorated subconjunctival implants.
Yavuz B; Bozdağ Pehlivan S; Kaffashi A; Çalamak S; Ulubayram K; Palaska E; Çakmak HB; Ünlü N
Drug Deliv; 2016 Nov; 23(9):3279-3284. PubMed ID: 27027148
[TBL] [Abstract][Full Text] [Related]
11. Physiologically active hydrogel (in situ gel) of sparfloxacin and its evaluation for ocular retention using gamma scintigraphy.
Gupta H; Malik A; Khar RK; Ali A; Bhatnagar A; Mittal G
J Pharm Bioallied Sci; 2015; 7(3):195-200. PubMed ID: 26229353
[TBL] [Abstract][Full Text] [Related]
12. Polymeric nanoparticles augment the ocular hypotensive effect of melatonin in rabbits.
Musumeci T; Bucolo C; Carbone C; Pignatello R; Drago F; Puglisi G
Int J Pharm; 2013 Jan; 440(2):135-40. PubMed ID: 23078856
[TBL] [Abstract][Full Text] [Related]
13. Conjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery.
Vasconcelos A; Vega E; Pérez Y; Gómara MJ; García ML; Haro I
Int J Nanomedicine; 2015; 10():609-31. PubMed ID: 25670897
[TBL] [Abstract][Full Text] [Related]
14. Engineering of polymer-surfactant nanoparticles of doxycycline hydrochloride for ocular drug delivery.
Pokharkar V; Patil V; Mandpe L
Drug Deliv; 2015; 22(7):955-68. PubMed ID: 24601827
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir.
Yang X; Shah SJ; Wang Z; Agrahari V; Pal D; Mitra AK
Drug Deliv; 2016 Sep; 23(7):2399-2409. PubMed ID: 25564964
[TBL] [Abstract][Full Text] [Related]
16. Betaxolol hydrochloride loaded chitosan nanoparticles for ocular delivery and their anti-glaucoma efficacy.
Jain K; Kumar RS; Sood S; Dhyanandhan G
Curr Drug Deliv; 2013 Oct; 10(5):493-9. PubMed ID: 23410069
[TBL] [Abstract][Full Text] [Related]
17. Development of acetazolamide-loaded, pH-triggered polymeric nanoparticulate in situ gel for sustained ocular delivery: in vitro. ex vivo evaluation and pharmacodynamic study.
Singh J; Chhabra G; Pathak K
Drug Dev Ind Pharm; 2014 Sep; 40(9):1223-32. PubMed ID: 23837522
[TBL] [Abstract][Full Text] [Related]
18. Porous silicon oxide-PLGA composite microspheres for sustained ocular delivery of daunorubicin.
Nan K; Ma F; Hou H; Freeman WR; Sailor MJ; Cheng L
Acta Biomater; 2014 Aug; 10(8):3505-12. PubMed ID: 24793657
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of a novel in situ gel of sparfloxacin for sustained ocular drug delivery: in vitro and ex vivo characterization.
Khan N; Aqil M; Imam SS; Ali A
Pharm Dev Technol; 2015; 20(6):662-9. PubMed ID: 24754411
[TBL] [Abstract][Full Text] [Related]
20. Development and in vitro evaluation of surface modified poly(lactide-co-glycolide) nanoparticles with chitosan-4-thiobutylamidine.
Grabovac V; Bernkop-Schnürch A
Drug Dev Ind Pharm; 2007 Jul; 33(7):767-74. PubMed ID: 17654025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]